𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting interleukin-6 receptor inhibits human oral squamous cell carcinoma-related angiogenesis

✍ Scribed by S. Shinriki; H. Jono; K. Ota; M. Ueda; M. Kudo; T. Ota; T. Sueyoshi; M. Ibusuki; Y. Yoshitake; Y. Ando; M. Shinohara


Book ID
116561557
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
86 KB
Volume
38
Category
Article
ISSN
0901-5027

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical significance of interleukin-6 a
✍ Yi-Fen Wang; Shyue-Yih Chang; Shyh-Kuan Tai; Wing-Yin Li; Liang-Shun Wang πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

## Background: Recent studies showed that interleukin-6 (il-6) played a role in tumor development. however, available information about the prognostic significance of il-6 and il-6 receptors (il-6r) for oral squamous cell carcinoma (oscc) is limited. ## Methods: Eighty-six patients with oscc were

RNAi targeting urokinase-type plasminoge
✍ Hao Zhou; Yaling Tang; Xinhua Liang; Xiaoqin Yang; Jing Yang; Guiquan Zhu; Min Z πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 809 KB

## Abstract It has been admitted that urokinase‐type plasminogen activator receptor (u‐PAR) is overexpressed in many human malignant tumors including oral squamous cell carcinoma (OSCC) and plays an important role in a variety of cancer key cellular events as a versatile signaling orchestrator. In